乔治临床( George Clinical ) is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence issued by the Department of Health on the 3rd April. This licence represents a significant step forward in 乔治临床( George Clinical )’s operations in Hong Kong, allowing them to apply for a Certificate of Clinical Trial on behalf of the sponsor and as such streamlining and speeding up the process of commencing a trial in Hong Kong.

“We are very pleased to announce the receipt of our Hong Kong Wholesale Dealer licence,” Evon Hui, Associate Director, East Asia said. “It is a strong endorsement of the work we are currently undertaking in Hong Kong and will allow us to build on our already robust operational delivery.”

乔治临床( George Clinical ) Hong Kong can now apply to import and/or export license(s) for Investigational Product shipments to and from the investigational sites after regulatory approval. Improving the start-up times by streamlining the process for 乔治临床( George Clinical )’s sponsors.